000			03206nam a22003855i 4500
001			86141
003			ES-MaUEC
005			20230207040545.0
007			cr nn 008mamaa
008			160818s2016 gw | s |||| 0|eng d
020			_a9783319395043
040			_aES-MaUEC
050		4	_aRC685.H8 _b2016 EB
082	0	4	_a616.12
100	1		_aCicero, Arrigo F. G. _999622 _0Local
245	1	0	_aHypertension and Metabolic Cardiovascular Risk Factors _cby Arrigo F G Cicero
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XIII, 102 páginas) _b31 ilustraciones, 13 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aPractical Case Studies in Hypertension Management _x2364-6632
505	0		_aClinical case 1: Adult Patient with Hypertension and Metabolic Syndrome -- Clinical case 2: Adult Patient with Hypertension and Diabetes -- Clinical case 3: Adult Patient with Hypertension and Familial Hypercholesterolemia -- Clinical case 4: Adult Patient with Hypertension and Hypertriglyceridemia -- Clinical case 5: Adult Patient with Hypertension and Obesity -- Clinical case 6: Adult Patient with Hypertension and Gout.
520	3		_aThe aim of this guide is to provide clinicians with practical reference for the management of hypertensive patients with other cardiovascular risk factors, which originate from impaired metabolic functions. With the aid of carefully selected, paradigmatic case studies, the physician will find sound advice for the best approach to common but often under-recognized clinical situations, and answers to practical questions that arise when a specific condition is not directly addressed in the guidelines. Question-and-answer sections will help the reader to identify at a glance the most complex steps in the diagnostic and therapeutic process. In a zreal worldy clinical setting, the hypertensive patient rarely presents with hypertension as the only cardiovascular risk factor, and is more likely to be affected by other metabolic risk factors, such as impairment of lipid metabolism, glucose homeostasis, and purine metabolism, and by overweight or obesity. These cases will serve as a basis for analyzing best practice, highlighting problems in diagnosis and treatment, and selecting the most appropriate management of patients with metabolic risk factors in everyday practice.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aAngiología _0comprobar BNE19923469484 _2embne _9146287
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-39504-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319395043
907			_a.b12954196 _b10-10-17 _c21-11-16
988			_aSpringer_Medicine_2016
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC685.H8 C534 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11596624 _z06-04-17
999			_c86141 _d86141 _x1